PAPER Ntymenou S, Tsantzali I, Kalamatianos T, Voumvourakis KI, Kapaki E, Tsivgoulis G, Stranjalis G, Paraskevas GP
SEARCH RESULTS
274072 RESULTS
PAPER Solano-Rojas B, Villalón-Fonseca R
A Low-Cost Three-Dimensional DenseNet Neural Network for Alzheimer's Disease Early Discovery.
Sensors (Basel). 2021 Feb 11;21(4) PubMed: 33670317PAPER Pereira Vatanabe I, Peron R, Mantellatto Grigoli M, Pelucchi S, De Cesare G, Magalhães T, Manzine PR, Figueredo Balthazar ML, Di Luca M, Marcello E, Cominetti MR
ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease.
Int J Mol Sci. 2021 Feb 28;22(5) PubMed: 33670873PAPER Marson F, Lasaponara S, Cavallo M
A Scoping Review of Neuromodulation Techniques in Neurodegenerative Diseases: A Useful Tool for Clinical Practice?
Medicina (Kaunas). 2021 Feb 27;57(3) PubMed: 33673455PAPER Friedman LG, McKeehan N, Hara Y, Cummings JL, Matthews DC, Zhu J, Mohs RC, Wang D, Hendrix SB, Quintana M, Schneider LS, Grundman M, Dickson SP, Feldman HH, Jaeger J, Finger EC, Michael Ryan J, Niehoff D, Dickinson SL, Markowitz JT, Owen M, Travaglia A, Fillit HM
Value-Generating Exploratory Trials in Neurodegenerative Dementias.
Neurology. 2021 Mar 5; PubMed: 33674360PAPER De Marchi F, Contaldi E, Magistrelli L, Cantello R, Comi C, Mazzini L
Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians.
Brain Sci. 2021 Feb 13;11(2) PubMed: 33668641PAPER Sivandzade F, Cucullo L
Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview.
Int J Mol Sci. 2021 Feb 22;22(4) PubMed: 33671500PAPER Salazar JG, Marsillach J, Reverte I, Mackness B, Mackness M, Joven J, Camps J, Colomina MT
Paraoxonase-1 and-3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer's Disease.
Antioxidants (Basel). 2021 Feb 24;10(3) PubMed: 33668379PAPER Zang Y, Liu K, Wang W, Li C, Ma J, Yang J, Chen X, Wang X, Zhang D
Claulansine F-Donepezil Hybrids as Anti-Alzheimer's Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities.
Molecules. 2021 Feb 28;26(5) PubMed: 33671020PAPER Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, Munter SE, Nixon CC, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Pulliam L
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations.
Cells. 2021 Feb 13;10(2) PubMed: 33668514PAPER Nazir N, Nisar M, Zahoor M, Uddin F, Ullah S, Ullah R, Ansari SA, Mahmood HM, Bari A, Alobaid A
Phytochemical Analysis, In Vitro Anticholinesterase, Antioxidant Activity and In Vivo Nootropic Effect of Ferula ammoniacum (Dorema ammoniacum) D. Don. in Scopolamine-Induced Memory Impairment in Mice.
Brain Sci. 2021 Feb 19;11(2) PubMed: 33669503PAPER Vasquez D, Castrillón MS, Vega MG, Henck CG, Aguillon D, Garcia-Cifuentes E, Jaramillo-Jimenez A, Velez JE, Madrigal L, Lopera F
Quality of life in early-onset Alzheimer's disease due to a PSEN1-E280A mutation.
Neurol Sci. 2021 Mar 5; PubMed: 33675003PAPER McMahon S, Bergink S, Kampinga HH, Ecroyd H
DNAJB chaperones suppress destabilised protein aggregation via a region unique from that used to inhibit amyloidogenesis.
J Cell Sci. 2021 Mar 5; PubMed: 33674449PAPER Abd Rashed A, Abd Rahman AZ, Rathi DN
Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review.
Molecules. 2021 Feb 19;26(4) PubMed: 33669787PAPER Amruta N, Chastain WH, Paz M, Solch RJ, Murray-Brown IC, Befeler JB, Gressett TE, Longo MT, Engler-Chiurazzi EB, Bix G
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.
Cytokine Growth Factor Rev. 2021 Feb 19; PubMed: 33674185Current Filters
- Date Range : All x